These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6127352)

  • 21. Tardive dyskinesia, mild drug-induced dyskinesia, and drug-induced parkinsonism: risk factors and topographic distribution.
    Akbostanci MC; Atbaşoğlu EC; Balaban H
    Acta Neurol Belg; 1999 Sep; 99(3):176-81. PubMed ID: 10544725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Epidemiology of tardive dyskinesias in the Maghreb].
    Moussaoui D; Douki S; Bentounsi B; Otarid A; Chorfi M; Mamou A; Benamor L
    Encephale; 1988 Sep; 14 Spec No():203-8. PubMed ID: 2905647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Focus on lower risk of tardive dyskinesia with atypical antipsychotics.
    Nasrallah HA
    Ann Clin Psychiatry; 2006; 18(1):57-62. PubMed ID: 16517454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tardive dyskinesia and plasma homovanillic acid.
    Moore DC; Glazer WM; Bowers MB; Heninger GR
    Biol Psychiatry; 1983 Dec; 18(12):1393-402. PubMed ID: 6140961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Withdrawal-emergent dyskinesia in patients with schizophrenia during antipsychotic discontinuation.
    Schultz SK; Miller DD; Arndt S; Ziebell S; Gupta S; Andreasen NC
    Biol Psychiatry; 1995 Dec; 38(11):713-9. PubMed ID: 8580223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of spontaneous dyskinesia in schizophrenia.
    Fenton WS
    J Clin Psychiatry; 2000; 61 Suppl 4():10-4. PubMed ID: 10739325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tardive dyskinesia and impaired glucose tolerance.
    Chong SA; Mythily ; Lum A; Huak CY; Kane J
    Hum Psychopharmacol; 2002 Aug; 17(6):305-7. PubMed ID: 12404676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tardive dyskinesia: prevalence, incidence, and risk factors.
    Kane JM; Woerner M; Lieberman J
    J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):52S-56S. PubMed ID: 3065365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prevalence of tardive dyskinesia in fluphenazine-treated patients.
    Yassa R; Iskandar H; Ally J
    J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):17S-20S. PubMed ID: 3220966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Shanghai 800: prevalence of tardive dyskinesia in a Chinese psychiatric hospital.
    Ko GN; Zhang LD; Yan WW; Zhang MD; Buchner D; Xia ZY; Wyatt RJ; Jeste DV
    Am J Psychiatry; 1989 Mar; 146(3):387-9. PubMed ID: 2563929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tardive dyskinesia in northern Israel: preliminary study.
    Schwartz M; Silver H; Tal I; Sharf B
    Eur Neurol; 1993; 33(3):264-6. PubMed ID: 8096816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gender differences in tardive dyskinesia: a critical review of the literature.
    Yassa R; Jeste DV
    Schizophr Bull; 1992; 18(4):701-15. PubMed ID: 1359633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiological aspects of tardive dyskinesia.
    Kane JM; Woerner M; Lieberman J
    Encephale; 1988 Sep; 14 Spec No():191-4. PubMed ID: 3063513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A survey of tardive dyskinesia in psychiatric inpatients in Japan.
    Koshino Y; Madokoro S; Ito T; Horie T; Mukai M; Isaki K
    Clin Neuropharmacol; 1992 Feb; 15(1):34-43. PubMed ID: 1349507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tardive Dyskinesia: analysis of outpatients with schizophrenia from Africa and the Middle East, Asia, Central and Eastern Europe, and Latin America.
    Kasper S; Lowry AJ; Hodge A; Bitter I; Dossenbach M
    Schizophr Res; 2006 Jan; 81(2-3):139-43. PubMed ID: 16253478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tardive dyskinesia in the course of antidepressant therapy: a prevalence study and review of the literature.
    Yassa R; Camille Y; Belzile L
    J Clin Psychopharmacol; 1987 Aug; 7(4):243-6. PubMed ID: 3624506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tardive dyskinesia in schizophrenics under 60 years of age.
    Kolakowska T; Williams AO; Ardern M; Reveley MA
    Biol Psychiatry; 1986 Feb; 21(2):161-9. PubMed ID: 2868762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent trend on the prevalence of tardive dyskinesia in Japan.
    Itoh H; Fujii Y; Kamisada M; Kamishima K; Koga Y; Masuda Y; Miura S; Nabeta Y; Nakano Y; Ogita K
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(1):39-49. PubMed ID: 6145187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of and risk factors for tardive dyskinesia in a Xhosa population in the Eastern Cape of South Africa.
    Patterson BD; Swingler D; Willows S
    Schizophr Res; 2005 Jul; 76(1):89-97. PubMed ID: 15927802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The significance of subtyping tardive dyskinesia: a study of prevalence and associated factors.
    Gureje O
    Psychol Med; 1989 Feb; 19(1):121-8. PubMed ID: 2567019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.